Fig. 4

Cost-effectiveness acceptability curves plotting the likelihood that attentive CTG is cost-effectivea
aCurves shown are for the model’s base-case analysis and for the various stage 2 analyses exploring reductions in the risk of severe compromise for additional babies correctly identified as at risk